Tower Research Capital LLC (TRC) - BIO BLAST PHARMA LTD ownership

BIO BLAST PHARMA LTD's ticker is ORPN and the CUSIP is M20156101. A total of 9 filers reported holding BIO BLAST PHARMA LTD in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BIO BLAST PHARMA LTD
ValueSharesWeighting
Q3 2016$0420.0%0.00%
Q2 2016$0
-100.0%
42
-82.6%
0.00%
Q1 2016$1,000
-83.3%
242
-84.6%
0.00%
-100.0%
Q4 2015$6,0001,572
+52300.0%
0.00%
Q3 2015$0
-100.0%
3
-99.5%
0.00%
Q1 2015$3,000
-50.0%
575
-34.0%
0.00%
-100.0%
Q4 2014$6,000
+200.0%
871
+190.3%
0.00%
Q3 2014$2,0003000.00%
Other shareholders
BIO BLAST PHARMA LTD shareholders Q3 2014
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 250,970$625,0000.25%
SABBY MANAGEMENT, LLC 1,133,937$2,824,0000.14%
Visium Asset Management, LP 713,625$1,777,0000.03%
OPPENHEIMER & CO INC 62,465$155,0000.01%
Virtu KCG Holdings LLC 21,771$54,0000.00%
UBS Group AG 1,698$4,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,000$2,0000.00%
MORGAN STANLEY 25$00.00%
Tower Research Capital LLC (TRC) 242$1,0000.00%
HighTower Advisors, LLC 35,700$86,0000.00%
View complete list of BIO BLAST PHARMA LTD shareholders